연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1701. A randomized, multicenter, phase II/III study to determine the optimal dose
and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.
Lee KH, Kim JY, Lee MH, Han HS, Lim JH, Park KU,
Park IH, Cho EK, Yoon SY, Kim JH, Choi IS, Park JH, Choi YJ, Kim HJ, Jung KH, Kim SY, Oh DY, Im SA.
Support Care Cancer. 2015 Oct 1.
[Epub ahead of print]
Link
1700. Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications.
Ock CY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ, Oh DY.
Gastric Cancer. 2015 May 23.
[Epub ahead of print]
Link
1699. Skeletal Muscle Depletion Predicts the Prognosis of Patients
with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y, Oh DY, Kim TY, Lee KH,
Han SW, Im SA, Kim TY, Bang YJ.
PLoS One.
2015 Oct 5;10(10):e0139749.
Link
1698. Concurrent Chemoradiotherapy Versus Chemotherapy Alone for
Unresectable Locally Advanced Pancreatic Cancer:
A Retrospective Cohort Study.
Choi Y, Oh DY, Kim K, Chie EK, Kim TY, Lee KH,
Han SW, Im SA, Kim TY, Ha SW, Bang YJ.
Cancer Res Treat. 2015 Oct 16.
[Epub ahead of print]
Link
1697. Phase II trial of dacomitinib in patients
with HER2-positive gastric cancer.
Oh DY, Lee KW, Cho JY, Kang WK, Im SA,
Kim JW, Bang YJ.
Gastric Cancer. 2015 Nov 18.
[Epub ahead of print]
Link
1696. Pertuzumab in gastrointestinal cancer.
Oh DY, Bang YJ.
Expert Opin Biol Ther. 2015 Nov 30.
[Epub ahead of print]
Link
1695. Signature of cytokines and angiogenic factors (CAFs)
defines a clinically distinct subgroup of gastric cancer.
Ock CY, Nam AR, Bang JH, Kim TY, Lee KH,
Han SW, Im SA, Kim TY, Bang YJ, Oh DY.
Gastric Cancer. 2015 Dec 17.
Link
1694. Epidermal growth factor-induced cell death and radiosensitization in epidermal growth factor receptor-overexpressing cancer cell lines.
Kim K1, Wu HG2, Jeon SR1.
Anticancer Res. 2015 Jan;35(1):245-53.
Link
1693. Tumor Growth Suppression and Enhanced Radioresponse by an Exogenous Epidermal Growth Factor in Mouse Xenograft Models with A431 Cells.
Lim YJ1, Jeon SR2, Koh JM3, Wu HG1,2,4.
Cancer Res Treat. 2015 Oct;47(4):921-30. doi: 10.4143/crt.2014.153. Epub 2015 Jan 7.
Link
1692. Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure.
Lim YJ1, Wu HG1,2,3, Kwon TK4, Hah JH4, Sung MW4, Kim KH4, Park CI1.
Cancer Res Treat. 2015 Oct;47(4):862-70. doi: 10.4143/crt.2014.203. Epub 2015 Feb 13.
Link